DEF: NeueHealth, Inc. Announces 2025 Annual Meeting of Stockholders and Proxy Statement

NeueHealth, Inc. is set to hold its 2025 Annual Meeting of Stockholders virtually on May 29, 2025, to vote on director elections, auditor ratification, executive compensation, and other business matters.

Summary

• NeueHealth, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on May 29, 2025.
• Stockholders of record as of April 28, 2025, are entitled to vote.
• The meeting will address the election of ten directors, ratification of Deloitte & Touche LLP as the independent accounting firm, an advisory vote on executive compensation, and other business.
• The Board recommends voting for all director nominees, ratifying the auditor, and approving executive compensation.
• The proxy statement and annual report are available online at www.proxyvote.com/NEUE and investors.neuehealth.com.
• As previously announced, on December 23, 2024, the Company entered into an Agreement and Plan of Merger with NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the NEA Merger as a wholly owned subsidiary of Parent.

Sentiment

Score: 7

Explanation: The document is primarily informational, outlining the details of the upcoming annual meeting and the matters to be voted on. The tone is professional and forward-looking, with management expressing confidence in the company's future. The merger announcement is a significant event, but the overall sentiment remains neutral to slightly positive.

Positives

• The company is providing a virtual meeting format for accessibility.
• Stockholders have multiple options for voting: online, phone, or mail.
• The Board is recommending actions that they believe are in the best interest of the company and its stockholders.
• The company has a Code of Conduct applicable to all employees, executive officers and directors that addresses legal and ethical issues that may be encountered in carrying out their duties and responsibilities, including the requirement to report any conduct they believe to be a violation of the Code of Conduct.

Negatives

• The company is being acquired by NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the NEA Merger as a wholly owned subsidiary of Parent.

Risks

• The proxy statement notes that the company is involved in a merger with NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., which could introduce uncertainty.
• The company's success depends on attracting and retaining talented employees in a competitive environment.
• The company's compensation programs must be carefully designed to avoid encouraging excessive risk-taking.
• The company is subject to the informational requirements of the Exchange Act and in accordance therewith, we file annual, quarterly and current reports and other information with the SEC.

Future Outlook

The company is focused on delivering value-driven, consumer-centric healthcare through its owned and affiliated clinics as well as enabling independent providers and medical groups to thrive in performance-based arrangements through deep financial alignment, customized population health tools, and strong partnerships with leading health plans and government programs.

Management Comments

• At our core, we are a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare.
• We believe we can significantly reduce the current friction and lack of coordination in todays healthcare system by aligning the interests of payors and providers to enable a seamless, consumer-centric healthcare experience that drives value for all.
• We are confident in the future of our differentiated, value-driven care model focused on our two go-forward business segments, NeueCare and NeueSolutions.

Industry Context

The healthcare industry continues to evolve and shift towards value-based care, which NeueHealth aims to address through its business segments.

Related Party Transactions

• The company is party to a registration rights agreement with certain of its stockholders including New Enterprise Associates, Bessemer Venture Partners, StepStone, Town Hall Ventures, and certain subsidiaries of Cigna and certain of their respective affiliates.
• On August 4, 2023, we entered into the 2023 Credit Agreement with NEA and the lenders from time to time party thereto, to provide for a credit facility pursuant to which, among other things, the lenders have provided an aggregated of $96.4 million delayed draw term loan commitments.
• On December 23, 2024, NeueHealth entered into an Agreement and Plan of Merger (the NEA Merger Agreement) with NH Holdings 2025, Inc., a Delaware corporation (Parent), and NH Holdings Acquisition 2025, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (Merger Sub), pursuant to which, among other things and on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into the Company (the NEA Merger), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

Stakeholder Impact

• Shareholders are being asked to vote on key decisions regarding the company's direction.
• The outcome of the votes will impact the composition of the Board and the company's governance.
• The merger will result in the company becoming a wholly owned subsidiary of Parent, which will impact shareholders.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• Attend the virtual Annual Meeting on May 29, 2025, if desired.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Board of Directors, Director Election, Executive Compensation, Deloitte & Touche LLP, Auditor Ratification, Corporate Governance, NeueHealth, Merger